These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 31480882)

  • 1. Intracellular crowding by age-dependent neuromelanin accumulation disrupts neuronal proteostasis and triggers Parkinson disease pathology.
    Vila M; Laguna A; Carballo-Carbajal I
    Autophagy; 2019 Nov; 15(11):2028-2030. PubMed ID: 31480882
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Brain tyrosinase overexpression implicates age-dependent neuromelanin production in Parkinson's disease pathogenesis.
    Carballo-Carbajal I; Laguna A; Romero-Giménez J; Cuadros T; Bové J; Martinez-Vicente M; Parent A; Gonzalez-Sepulveda M; Peñuelas N; Torra A; Rodríguez-Galván B; Ballabio A; Hasegawa T; Bortolozzi A; Gelpi E; Vila M
    Nat Commun; 2019 Mar; 10(1):973. PubMed ID: 30846695
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo reduction of age-dependent neuromelanin accumulation mitigates features of Parkinson's disease.
    Gonzalez-Sepulveda M; Compte J; Cuadros T; Nicolau A; Guillard-Sirieix C; Peñuelas N; Lorente-Picon M; Parent A; Romero-Giménez J; Cladera-Sastre JM; Laguna A; Vila M
    Brain; 2023 Mar; 146(3):1040-1052. PubMed ID: 36717986
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuromelanin, aging, and neuronal vulnerability in Parkinson's disease.
    Vila M
    Mov Disord; 2019 Oct; 34(10):1440-1451. PubMed ID: 31251435
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alpha-synuclein redistributes to neuromelanin lipid in the substantia nigra early in Parkinson's disease.
    Halliday GM; Ophof A; Broe M; Jensen PH; Kettle E; Fedorow H; Cartwright MI; Griffiths FM; Shepherd CE; Double KL
    Brain; 2005 Nov; 128(Pt 11):2654-64. PubMed ID: 16000336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toxic Feedback Loop Involving Iron, Reactive Oxygen Species, α-Synuclein and Neuromelanin in Parkinson's Disease and Intervention with Turmeric.
    Jansen van Rensburg Z; Abrahams S; Bardien S; Kenyon C
    Mol Neurobiol; 2021 Nov; 58(11):5920-5936. PubMed ID: 34426907
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Melanin and Neuromelanin: Linking Skin Pigmentation and Parkinson's Disease.
    Krainc T; Monje MHG; Kinsinger M; Bustos BI; Lubbe SJ
    Mov Disord; 2023 Feb; 38(2):185-195. PubMed ID: 36350228
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuromelanin accumulation drives endogenous synucleinopathy in non-human primates.
    Chocarro J; Rico AJ; Ariznabarreta G; Roda E; Honrubia A; Collantes M; Peñuelas I; Vázquez A; Rodríguez-Pérez AI; Labandeira-García JL; Vila M; Lanciego JL
    Brain; 2023 Dec; 146(12):5000-5014. PubMed ID: 37769648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The roles of neuromelanin, binding of metal ions, and oxidative cytotoxicity in the pathogenesis of Parkinson's disease: a hypothesis.
    Enochs WS; Sarna T; Zecca L; Riley PA; Swartz HM
    J Neural Transm Park Dis Dement Sect; 1994; 7(2):83-100. PubMed ID: 7710667
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo imaging of neuromelanin in Parkinson's disease using 18F-AV-1451 PET.
    Hansen AK; Knudsen K; Lillethorup TP; Landau AM; Parbo P; Fedorova T; Audrain H; Bender D; Østergaard K; Brooks DJ; Borghammer P
    Brain; 2016 Jul; 139(Pt 7):2039-49. PubMed ID: 27190023
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Residual substantia nigra neuromelanin in Parkinson's disease is cross-linked to alpha-synuclein.
    Fasano M; Giraudo S; Coha S; Bergamasco B; Lopiano L
    Neurochem Int; 2003 Jun; 42(7):603-6. PubMed ID: 12590943
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New face of neuromelanin.
    Double KL; Halliday GM
    J Neural Transm Suppl; 2006; (70):119-23. PubMed ID: 17017518
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interactions of iron, dopamine and neuromelanin pathways in brain aging and Parkinson's disease.
    Zucca FA; Segura-Aguilar J; Ferrari E; Muñoz P; Paris I; Sulzer D; Sarna T; Casella L; Zecca L
    Prog Neurobiol; 2017 Aug; 155():96-119. PubMed ID: 26455458
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction between Neuromelanin and Alpha-Synuclein in Parkinson's Disease.
    Xu S; Chan P
    Biomolecules; 2015 Jun; 5(2):1122-42. PubMed ID: 26057626
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased expression of α-synuclein in aged human brain associated with neuromelanin accumulation.
    Xuan Q; Xu SL; Lu DH; Yu S; Zhou M; Uéda K; Cui YQ; Zhang BY; Chan P
    J Neural Transm (Vienna); 2011 Nov; 118(11):1575-83. PubMed ID: 21461961
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Substantia nigra neuromelanin magnetic resonance imaging in de novo Parkinson's disease patients.
    Reimão S; Pita Lobo P; Neutel D; Correia Guedes L; Coelho M; Rosa MM; Ferreira J; Abreu D; Gonçalves N; Morgado C; Nunes RG; Campos J; Ferreira JJ
    Eur J Neurol; 2015 Mar; 22(3):540-6. PubMed ID: 25534480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The role of neuromelanin in Parkinson's disease--new concepts].
    Stepień K; Dzierzega-Lecznar A; Tam I
    Wiad Lek; 2007; 60(11-12):563-9. PubMed ID: 18540183
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The enigma of neuromelanin in Parkinson's disease substantia nigra.
    Youdim MB; Ben-Shachar D; Riederer P
    J Neural Transm Suppl; 1994; 43():113-22. PubMed ID: 7884393
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Magnetic resonance correlation of iron content with neuromelanin in the substantia nigra of early-stage Parkinson's disease.
    Reimão S; Ferreira S; Nunes RG; Pita Lobo P; Neutel D; Abreu D; Gonçalves N; Campos J; Ferreira JJ
    Eur J Neurol; 2016 Feb; 23(2):368-74. PubMed ID: 26518135
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modifications of the iron-neuromelanin system in Parkinson's disease.
    Fasano M; Bergamasco B; Lopiano L
    J Neurochem; 2006 Feb; 96(4):909-16. PubMed ID: 16417570
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.